SCHEMBL6023713

SCHEMBL6023713

Cc1onc(-c2ccccc2)c1-c1ccc(S(=O)(=O)CCC(N)=O)cc1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS2 P35354 14/20 0.65
▸ PTGS1 P23219 4/20 0.65
▸ MT-CO2 P00403 3/20 0.65
▸ CA12 O43570 1/20 0.65
▸ CA1 P00915 1/20 0.65
▸ CA2 P00918 1/20 0.65
▸ LMNA P02545 1/20 0.65
▸ CA3 P07451 1/20 0.65
▸ ADRB2 P07550 1/20 0.65
▸ ADRB1 P08588 1/20 0.65
▸ CYP3A4 P08684 1/20 0.65
▸ ADORA3 P0DMS8 1/20 0.65
▸ CHRM1 P11229 1/20 0.65
▸ ADRA2B P18089 1/20 0.65
▸ CA4 P22748 1/20 0.65
▸ CA6 P23280 1/20 0.65
▸ SLC6A2 P23975 1/20 0.65
▸ PDE4A P27815 1/20 0.65
▸ ADORA1 P30542 1/20 0.65
▸ CA5A P35218 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28275572 0.99 PTGS2 (0.63) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL28237482 0.89 PTGS2 (0.53) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL21602623 0.85 PTGS2 (0.61) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL6167916 0.83 PTGS2 (0.67) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL8351119 0.80 PTGS2 (0.69) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL12103408 0.80 PTGS2 (0.62) PTGS2PTGS1MT-CO2CA12CA1
Valdecoxib SCHEMBL3356 0.79 PTGS2 (1.00) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL6013897 0.79 PTGS2 (0.76) PTGS2PTGS1MT-CO2CA12CA1
SCHEMBL6168344 0.79 PTGS2 (1.00) PTGS2PTGS1MT-CO2CA12CA1
Valdecoxib SCHEMBL3853130 0.79 PTGS2 (1.00) PTGS2PTGS1MT-CO2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060154954-A1 Combinations and use of selected pharmaceutically active compounds ALTANA PHARMA AG (DE) 2006-07-13 — — US claimed
EP-1599175-A2 IMIDAZOPYRIDINES CONTAINING COMBINATIONS AND THEIR USE IN TREATING GASTROINTESTINAL INFLAMMATORY DISORDERS ALTANA Pharma AG (DE) 2005-11-30 — — EP claimed
WO-2005074930-A1 PHARMACEUTICAL COMBINATIONS OF (S) -PANTOPRAZOLE WITH NSAID OR CORTICOSTEROIDS ALTANA PHARMA AG (DE) 2005-08-18 — — WO claimed
WO-2004071391-A2 IMIDAZOPYRIDINES CONTAINING COMBINATIONS AND THEIR USE IN TREATING GASTROINTESTINAL INFLAMMATORY DISORDERS ALTANA PHARMA AG (DE) 2004-08-26 — — WO claimed
US-20060154954-A1 Combinations and use of selected pharmaceutically active compounds ALTANA PHARMA AG (DE) 2006-07-13 — — US disclosed
EP-1599175-A2 IMIDAZOPYRIDINES CONTAINING COMBINATIONS AND THEIR USE IN TREATING GASTROINTESTINAL INFLAMMATORY DISORDERS ALTANA Pharma AG (DE) 2005-11-30 — — EP disclosed
WO-2005074930-A1 PHARMACEUTICAL COMBINATIONS OF (S) -PANTOPRAZOLE WITH NSAID OR CORTICOSTEROIDS ALTANA PHARMA AG (DE) 2005-08-18 — — WO disclosed
WO-2004071391-A2 IMIDAZOPYRIDINES CONTAINING COMBINATIONS AND THEIR USE IN TREATING GASTROINTESTINAL INFLAMMATORY DISORDERS ALTANA PHARMA AG (DE) 2004-08-26 — — WO disclosed
Send feedback